Published in
BMJ Publishing Group, BMJ, apr15 5(346), p. f2023-f2023
DOI: 10.1136/bmj.f2023
Links
- ORCID
- BMJ Publishing Group | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [lup.lub.lu.se] | PDF
- [europepmc.org] | PDF
- [portal.research.lu.se] | PDF
Tools
Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study
Journal article published in 2013 by
Andrew J. Vickers 
,
David Ulmert,
Daniel D. Sjoberg,
Caroline J. Bennette,
Thomas Björk,
Axel Gerdtsson,
Jonas Manjer,
Peter M. Nilsson,
Anders Dahlin,
Anders Bjartell,
Peter T. Scardino,
Hans Lilja
,
David Ulmert,
Daniel D. Sjoberg,
Caroline J. Bennette,
Thomas Björk,
Axel Gerdtsson,
Jonas Manjer,
Peter M. Nilsson,
Anders Dahlin,
Anders Bjartell,
Peter T. Scardino,
Hans Lilja
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
Objective To determine the association between concentration of prostate specific antigen (PSA) at age 40-55 and subsequent risk of prostate cancer metastasis and mortality in an unscreened population to evaluate when to start screening for prostate cancer and whether rescreening could be risk stratified.